Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absorption, Metabolism and Excretion of [14C]Chiauranib in Patients With Small Cell Lung Cancer

NCT05371899 is registered in ClinicalTrials.gov with Chipscreen Biosciences, Ltd. as lead sponsor.

NCT NCT05371899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05371899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absorption, Metabolism and Excretion of [14C]Chiauranib in Patients With Small Cell Lung Cancer
Lead sponsor
Chipscreen Biosciences, Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2022
Completion date
March 18, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer